Hauge E M, Balling E, Hartmund T, Hjortdal V E
Institute of Experimental Clinical Research, University Hospital of Aarhus, Denmark.
Plast Reconstr Surg. 1997 Mar;99(3):825-33. doi: 10.1097/00006534-199703000-00032.
Ischemia-reperfusion injury is one of the major problems in reconstructive microsurgery. The ischemic insult may be due to an occlusion of either the artery or the vein. Clinical observations have suggested that flap survival is more sensitive to venous stasis than to arterial ischemia. The current study evaluated the viability of the myocutaneous rectus abdominis flap following secondary arterial or venous occlusion and its possible dependency on tissue metabolites and length of the preceding reperfusion period. Forty-eight bilateral 5 X 10 cm myocutaneous rectus abdominis flaps were elevated in 24 pigs and exposed to consecutive periods of primary ischemia (2 hours), reperfusion (1, 4, 8, and 12 hours), and secondary pedicle occlusion (6, 8, 10, 12, 14, or 16 hours) of arterial or venous origin. Muscle adenosine triphosphate (ATP) and glucose-6-phosphate (G6P) were assessed immediately after flap elevation, at the end of primary ischemia, after reperfusion, and at the end of secondary ischemia. Flap viability was assessed 5 days after the operation. Secondary venous occlusion resulted in reduced survival rates as compared with arterial occlusion (9 of 24 versus 20 of 24; p < 0.01), although the average ATP content was higher in flaps subjected to venous stasis [median (25 to 75) percentiles, 3.7 (1.7 to 7.1) micromol/gm protein] than in those subjected to arterial ischemia 1.2 (0.8 to 1.8 micromol/gm protein) (p < 0.01). During reperfusion, muscle ATP decreased from 28.5 (17.9 to 36.6) micromol/gm protein to 15.4 (7.4 to 24.9) micromol/gm protein (p < 0.01) and glucose-6-phosphate from 7.6 (4.1 to 11.6) micromol/gm protein to 1.0 (0.5 to 4.1) micromol/gm protein (p < 0.01). Still, flap survival following secondary arterial ischemia was improved by increasing the reperfusion time from 1 to 8 hours (p < 0.05). No effect of reperfusion time was seen on viability after venous stasis. In conclusion, despite poorer flap survival, venous stasis was less detrimental to tissue ATP level, suggesting that the continued inflow may have supplied substrates for glycolysis. Furthermore, the larger blood volume may have accumulated the glycolytic waste products. After reperfusion, the recovery of aerobic metabolism was far from complete, and cellular glycolytic substrates were nearly exhausted. However, prolongation of the reperfusion time preceding secondary arterial ischemia improved flap survival.
缺血再灌注损伤是显微重建外科手术中的主要问题之一。缺血性损伤可能是由于动脉或静脉闭塞所致。临床观察表明,皮瓣存活对静脉淤血比对动脉缺血更敏感。本研究评估了腹直肌肌皮瓣在继发动脉或静脉闭塞后的存活能力,及其对组织代谢物和先前再灌注时间的可能依赖性。在24头猪身上掀起48个双侧5×10 cm的腹直肌肌皮瓣,并使其依次经历原发性缺血(2小时)、再灌注(1、4、8和12小时)以及继发的动脉或静脉蒂闭塞(6、8、10、12、14或16小时)。在皮瓣掀起后、原发性缺血结束时、再灌注后以及继发性缺血结束时,评估肌肉三磷酸腺苷(ATP)和6 - 磷酸葡萄糖(G6P)。在术后5天评估皮瓣存活情况。与动脉闭塞相比,继发静脉闭塞导致存活率降低(24例中9例与24例中20例;p < 0.01),尽管静脉淤血皮瓣的平均ATP含量[中位数(25%至75%百分位数),3.7(1.7至7.1)μmol/g蛋白质]高于动脉缺血皮瓣[1.2(0.8至1.8)μmol/g蛋白质](p < 0.01)。在再灌注期间,肌肉ATP从28.5(17.9至36.6)μmol/g蛋白质降至15.4(7.4至24.9)μmol/g蛋白质(p < 0.01),6 - 磷酸葡萄糖从7.6(4.1至11.6)μmol/g蛋白质降至1.0(0.5至4.1)μmol/g蛋白质(p < 0.01)。尽管如此,将再灌注时间从1小时增加到8小时可改善继发动脉缺血后的皮瓣存活情况(p < 0.05)。再灌注时间对静脉淤血后的存活能力没有影响。总之,尽管皮瓣存活较差,但静脉淤血对组织ATP水平的损害较小,这表明持续的血流可能为糖酵解提供了底物。此外,较大的血容量可能积聚了糖酵解废物。再灌注后,有氧代谢的恢复远未完成,细胞糖酵解底物几乎耗尽。然而,延长继发动脉缺血前的再灌注时间可提高皮瓣存活率。